Alaunos Therapeutics (TCRT) Short-term Investments (2022 - 2023)
Alaunos Therapeutics (TCRT) reported Short-term Investments of $13.9 million for Q1 2023, little changed quarter-over-quarter from $13.9 million in Q4 2022.
Alaunos Therapeutics (TCRT) Short-term Investments (2022 - 2023) Analysis & Trends
Alaunos Therapeutics has reported Short-term Investments for 2 years, with the latest figure at $13.9 million in Q1 2023.
- For the quarter ending Q1 2023, Short-term Investments changed N/A year-over-year to $13.9 million; the trailing twelve-month figure through Mar 2023 stood at $13.9 million (changed N/A YoY), and the FY2022 full-year result was $13.9 million, changed N/A from the prior year.
- Short-term Investments for Q1 2023 stood at $13.9 million, roughly flat from $13.9 million in the prior quarter.
- The five-year high for Short-term Investments was $13.9 million in Q3 2022, with the low at $13.9 million in Q3 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Alaunos Therapeutics | 4.31 Mn | 3.95 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 13.94 Mn |
| Dec 31, 2022 | 13.94 Mn |
| Sep 30, 2022 | 13.94 Mn |